Nevakar Inc.

About

Nevakar Inc is a specialty pharmaceutical company based in Bridgewater, New Jersey, focused on developing and commercializing innovative injectable and ophthalmic products. Founded in 2015, the company specializes in repositioning existing FDA-approved molecules to create enhanced therapeutic solutions that address unmet medical needs and improve patient outcomes. The company operates through advanced research and development capabilities, utilizing state-of-the-art infrastructure to design specialized generic injectable and ophthalmic formulations. Nevakar employs multiple development strategies including studying new therapeutic indications for existing molecules, developing superior formulations, and designing improved packaging solutions. Their products are primarily filed with the FDA under the 505(b)(2) regulatory pathway, enabling faster market entry while maintaining high safety standards. Nevakar maintains an established portfolio of products focused on critical patient care, acute pain management, long-acting injectables, and hospital infection treatments. The company recently formed Nevakar Injectables Inc., expanding their commercial presence in the sterile pharmaceutical manufacturing sector. With 51-200 employees and significant investment backing, including 248 million dollars in funding, Nevakar combines proven expertise in sterile pharmaceutical development with innovative regulatory strategies. Their business model emphasizes creating proprietary enhancements to existing molecules through intensive research and clinical efforts, positioning them as a leader in pharmaceutical repositioning and injectable drug development within the competitive pharmaceutical manufacturing landscape.